NCT00229710 · Interventional trial
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
Overall registry status Terminated
Phase 3
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory